MAXHEALTH
Max Healthcare Institute, a prominent player in the Hospital & Healthcare Services sector, The company has reported negative financial performance for the third quarter of FY24-25, raising questions about its current standing. Despite these challenges, Max Healthcare maintains a low debt-to-equity ratio of 0.03 times, indicating a manageable level of debt. The company has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 35.32% and operating profit soaring by 93.40%. The stock is currently in a mildly bullish range, with technical indicators such as the RSI and Bollinger Bands showing positive trends. Max Healthcare boasts high institutional holdings at 72.49%, suggesting strong backing from investors with substantial analytical resources. Over the past three years, the company has consistently outperformed the BSE 500, generating a return of 37.67% in the last year alone. With a market capitalization of Rs 97,214 crore, it represents 21.29% of the sector, although it has faced negative results for the last three consecutive quarters.

















